SDX AACR 2023 poster 05Apr 2023.pptx
PRESS RELEASE • APR 14, 2023 08:00 EDT
Evexomostat (SDX-7320) shows potent anti-tumor effects in pre-clinical models of prostate cancer, including castration-resistant. New research data to be presented at AACR 2023 in Orlando, FL
